Jinji Yang

Guangdong Provincial Key Laboratory Of Translational Medicine In Lung Cancer
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Advances in the Treatment of RET Fusion-positive Advanced Non-small Cell Lung Cancer

Advances in the Treatment of RET Fusion-positive Advanced Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: November 08, 2021

Predictable Roles of Peripheral IgM Memory B Cells for the Responses to Anti-PD-1 Monotherapy Against Advanced Non-Small Cell Lung Cancer.

Predictable Roles of Peripheral IgM Memory B Cells for the Responses to Anti-PD-1 Monotherapy Against Advanced Non-Small Cell Lung Cancer.

Journal: Frontiers in immunology

Published: August 16, 2021

Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trial.

Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trial.

Journal: Annals of translational medicine

Published: March 12, 2021

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.

Journal: Cancer biology & medicine

Published: May 24, 2019

Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level.

Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level.

Journal: BMC cancer

Published: April 21, 2018

Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients.

Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients.

Journal: Oncotarget

Published: February 25, 2017

Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R.

Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: August 02, 2016

Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.

Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.

Journal: Thoracic cancer

Published: April 30, 2016

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma.

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma.

Journal: Oncotarget

Published: April 16, 2016

Guideline for diagnosis and treatment of ALK positive non-small cell lung cancer in China

Guideline for diagnosis and treatment of ALK positive non-small cell lung cancer in China

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: December 26, 2015

Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma

Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma

Journal: Zhonghua yi xue za zhi

Published: November 18, 2014

Complete remission and fatal interstitial pneumonitis related to nab-paclitaxel in refractory small cell lung cancer: A case report and review of the literature.

Complete remission and fatal interstitial pneumonitis related to nab-paclitaxel in refractory small cell lung cancer: A case report and review of the literature.

Journal: Thoracic cancer

Published: February 01, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026